,25 Our study extends the results of these studies by linking variation at these loci with a clinical diagnosis of NAFLD and identifies LPL as a potential new susceptibility locus for NAFLD. This evidence concerns the gene LPL and metabolic dysfunction-associated steatotic liver disease.